The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO
- PMID: 17222913
- PMCID: PMC3501193
- DOI: 10.1016/j.pharmthera.2006.11.002
The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO
Abstract
Nitroxyl (HNO), the 1-electron reduced and protonated congener of nitric oxide (NO), has received recent attention as a potential pharmacological agent for the treatment of heart failure and as a preconditioning agent for the mitigation of ischemia-reperfusion injury. Interest in the pharmacology and biology of HNO has prompted examination, or in some instances reexamination, of many of its chemical properties. Such studies have provided insight into the chemical basis for the biological effects of HNO, although the biochemical mechanisms for many of these effects remain to be established. In this review, a brief description of the biologically relevant chemistry of HNO is given, followed by a more detailed discussion of the pharmacology and potential toxicology of HNO.
References
-
- Angeli A. Gazz. Chim. Ital. 1903;33(II):245.
-
- Atkinson RN, Storey BM, King SB. Reactions of acylnitroso compounds with amines: Production of nitroxyl (HNO) with the preparation of amides. Tet. Lett. 1996;37:9287–9290.
-
- Bai P, Bakondi E, Szabo E, Gergely P, Szabo C, Virag L. Partial protection by poly(ADP-ribose) polymerase inhibitors from nitroxyl-induced cytotoxity in thymocytes. Free Rad. Biol. Med. 2001;31:1616–23. - PubMed
-
- Bari SE, Marti MA, Amorebieta VT, Estrin DA, Doctorovich F. Fast nitroxyl trapping by ferric porphyrins. J. Am. Chem. Soc. 2003;125:15272–15273. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
